Operations: Eckert & Ziegler SE generates revenue primarily from its Medical (€132.80 million) and Isotopes Products (€150.97 million) segments, with a total revenue of €283.76 million after accounting for eliminations and adjustments.

Earnings for Eckert & Ziegler grew by 31.6% over the past year, outpacing the Medical Equipment industry’s 16.2% growth rate. The company reported Q2 sales of €77.76M, up from €60.03M last year, with net income rising to €9.54M from €6.17M previously. Trading at 82% below its estimated fair value and having reduced its debt-to-equity ratio from 14.7% to 9.5% over five years, EUZ appears undervalued and financially robust with high-quality earnings and strong EBIT coverage of interest payments (20x).

• Click here to discover the nuances of Eckert & Ziegler with our detailed analytical health report.

• Explore historical data to track Eckert & Ziegler's performance over time in our Past section.

KSB SE KGaA

Simply Wall St Value Rating: ★★★★★★

Overview: KSB SE & Co. KGaA, with a market cap of €1.08 billion, manufactures and supplies pumps, valves, and related services globally through its subsidiaries.

Operations: KSB SE & Co. KGaA generates revenue primarily from three segments: Pumps (€1.52 billion), Fittings (€370.94 million), and KSB Supremeserv (€978.20 million). The company's net profit margin is 3.5%.

KSB SE KGaA, a notable player in the machinery industry, has shown resilience despite a €102.5M one-off loss impacting its financials as of June 2024. Trading at 78.2% below its estimated fair value and with earnings growth of 16.8% last year, it outpaced the broader machinery sector's -4%. The company’s debt to equity ratio impressively dropped from 9.2% to 0.8% over five years, reflecting robust financial management and strategic positioning for future growth.

• Navigate through the intricacies of KSB SE KGaA with our comprehensive health report here.

• Evaluate KSB SE KGaA's historical performance by accessing our past performance report.

Summing It All Up

• Take a closer look at our German Undiscovered Gems With Strong Fundamentals list of 56 companies by clicking here.

• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.

• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include XTRA:EKT XTRA:EUZ and XTRA:KSB.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]